Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Depreciation and Depletion: 2018-2024

Historic Depreciation and Depletion for Avidity Biosciences (RNA) over the last 7 years, with Dec 2024 value amounting to $2.8 million.

  • Avidity Biosciences' Depreciation and Depletion rose 57.14% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 31.04%. This contributed to the annual value of $2.8 million for FY2024, which is 33.27% up from last year.
  • Latest data reveals that Avidity Biosciences reported Depreciation and Depletion of $2.8 million as of FY2024, which was up 33.27% from $2.1 million recorded in FY2023.
  • Avidity Biosciences' 5-year Depreciation and Depletion high stood at $2.8 million for FY2024, and its period low was $400,000 during FY2020.
  • For the 3-year period, Avidity Biosciences' Depreciation and Depletion averaged around $2.1 million, with its median value being $2.1 million (2023).
  • Data for Avidity Biosciences' Depreciation and Depletion shows a peak YoY surged of 119.09% (in 2022) over the last 5 years.
  • Over the past 5 years, Avidity Biosciences' Depreciation and Depletion (Yearly) stood at $400,000 in 2020, then skyrocketed by 59.75% to $639,000 in 2021, then skyrocketed by 119.09% to $1.4 million in 2022, then spiked by 50.07% to $2.1 million in 2023, then soared by 33.27% to $2.8 million in 2024.